peptide stability comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Updated 2025-11-26. Numbers and descriptions here follow the published literature rather than marketing material.
Clinical development has progressed through phase 2 trials in adults with obesity and type 2 diabetes, with phase 3 programs reported as ongoing. Reported outcomes include reductions in body weight and improvements in glycemic measures over defined treatment periods. Whether these effects translate into durable benefits after treatment ends remains an open question. Long-term safety data across broad populations are not yet complete, and regulatory decisions have not been announced.
Retatrutide is an investigational synthetic peptide engineered to activate three distinct hormone receptors within a single molecule. It targets the glucose-dependent insulinotropic polypeptide receptor, the glucagon-like peptide-1 receptor, and the glucagon receptor simultaneously. This triagonist design distinguishes it from earlier incretin-based compounds that act on one or two of these pathways. Structural modifications relative to native gut hormones extend its residence time in circulation. The molecule remains under clinical evaluation and is not approved for any indication.
retatrutide 是一种人工合成的多肽，设计目标是同时作用于 GIP、GLP-1 与胰高血糖素三种受体。这种三重激动设计试图把多条代谢通路的调节整合进单一分子，而不是只依赖一种肠促胰素受体。分子骨架以天然肽序列为基础，经过非天然氨基酸替换和脂肪酸侧链修饰，以获得更长的作用时间。该方向属于多受体激动剂研究的一部分，与双重激动剂的工作并行推进。
三种受体在能量平衡中的分工并不相同：GLP-1 与 GIP 受体主要参与胰岛素分泌和食欲调节，胰高血糖素受体则与能量消耗及肝糖输出相关。同时激活三者可能产生叠加效应，也可能出现相互制约，具体结果取决于受体亲和力与组织分布。这种组合在理论上可能同时影响体重与血糖指标，但协同关系的细节仍处在研究阶段。
化学修饰延长了分子在体内的停留时间，使较低频次的给药安排成为可能。脂肪酸侧链通过与白蛋白结合延缓清除，非天然氨基酸则降低酶解速率。这些修饰同时改变分子的溶解性与稳定性，需要在制剂设计和储存条件中一并考虑。修饰引入的免疫原性风险也属于开发过程中需要评估的项目。
| Property | Value | Notes |
|---|---|---|
| Receptor targets | GIP, GLP-1, glucagon | One molecule activates all three pathways |
| Research identifier | LY3437943 | Code used in published trial reports |
| Development stage | Phase 3, reported as ongoing | Not approved by any regulatory agency |
| Route studied | Subcutaneous | Administration form used in clinical trials |
| Studied populations | Adults with obesity or type 2 diabetes | Enrollment criteria vary between trials |
Development has progressed from single- and multiple-ascending-dose studies in healthy volunteers into larger randomized trials in adults with obesity, type 2 diabetes, and fatty liver disease. Early reports describe dose-dependent reductions in body weight and improvements in glycemic markers over treatment periods of several months. Whether the glucagon arm adds tolerability cost without added benefit is still debated. Long-term cardiovascular outcomes, effects after treatment stops, and performance in older or comorbid populations are open questions rather than settled findings. Approval status may change, so the current investigational label should be confirmed against regulatory sources.
Retatrutide is an investigational synthetic peptide developed under the code LY3437943, with a backbone derived from glucose-dependent insulinotropic polypeptide. Several non-proteinogenic residues, including alpha-aminoisobutyric acid, appear in that backbone, and a fatty diacid side chain attached through a linker extends circulation time. The molecule carries roughly thirty-nine amino acid units and a total mass near 4.7 kilodaltons. Administration is by subcutaneous injection once weekly. Published work uses both the name retatrutide and the code LY3437943.
Identification and purity assessment typically rely on reversed-phase high-performance liquid chromatography, often paired with mass spectrometry. Mass measurement confirms the expected molecular mass and can reveal truncations or modifications. Peptide mapping and sequencing techniques provide sequence-level confirmation when needed. Because related peptide impurities can behave similarly in a single method, orthogonal techniques are usually combined. Reported purity values depend heavily on the method used and should be interpreted with that in mind.
Dissolution behavior depends on the amino acid sequence, the counterion content, and the buffer chosen. Many peptides disperse readily in water or mild aqueous buffers, while others require a small amount of organic co-solvent or a change in pH. Adsorption to plastic and glass surfaces can reduce the concentration of a solution over time, particularly at low concentrations. Filtration before analysis removes particulates, and aliquoting limits repeated freeze-thaw cycles that stress the material.
Human evidence remains limited to controlled studies. A phase 2 trial in adults with obesity reported large, dose-dependent reductions in body weight over 48 weeks, with gastrointestinal events as the most frequently recorded adverse effect. Phase 3 programs designated TRIUMPH, for obesity, and TRANSCEND, for type 2 diabetes, are intended to confirm efficacy and to characterize safety in larger populations. Related studies are examining conditions such as knee osteoarthritis in people with obesity and metabolic liver disease. Open questions include long-term tolerability, effects on lean mass, and what happens after treatment is stopped.
Retatrutide is an investigational synthetic peptide that acts on three receptor targets at once: glucose-dependent insulinotropic polypeptide, glucagon-like peptide-1, and glucagon. It is developed by Eli Lilly and appears in the literature and in trial registries under the code LY3437943. The molecule belongs to a class of engineered peptides designed to resist rapid breakdown and permit infrequent subcutaneous administration. No regulatory agency has approved it for clinical use, and all available human data come from controlled trials rather than from routine practice.
In Germany, there are different types of Eiskaffee (coffee with ice cream). The most widespread form includes milk and sweeteners, and is served in coffeehouses and in Eisdielen (ice cream parlours). It consists of filtered, hot brewed and cooled coffee with vanilla ice cream and whipped cream on top. In supermarkets, the most common canned version includes flavors such as cappuccino and espresso. This iced coffee is very similar to the canned iced coffee in the UK and in the case of some brands (particularly Nestlé) actually the same product.
=== Minor characters === Dimitri Chandler: Captain of the Goliath, Chandler mines the outer solar system for ice material which is slowly pushed towards the inner solar system, to make the inner planets habitable through long-term terraforming. Professor Anderson: a medical doctor, Anderson leads the medical team which revived Poole, and works with Indra Wallace both to aid Poole's convalescence, and also to manage his cultural shock at awakening into a strange future world. Dr. Stephen Del Marco: Alive at a future time (2513 AD) which is yet in the novel's distant past, Del Marco is the discoverer of TMA-0 in Africa: an earthbound monolith matching the lunar monolith which had been discovered hundreds of years earlier, in 2001. Dr. Theodore "Ted" Khan: A resident of Ganymede, Dr. Khan is contemptuous of religion, identifying it as a mental disorder.
===== MeSH D08.811.913.200 – aldehyde-ketone transferases (EC 2.2) ===== MeSH D08.811.913.200.324 – acetolactate synthase MeSH D08.811.913.200.650 – transaldolase MeSH D08.811.913.200.825 – transketolase
== Background == The Government of India and UNESCO signed a Memorandum of Understanding (MoU) on 14 July 2006 to establish RCB. The centre is now recognized as a "Category II Centre" by "the principles and guidelines for the establishment and functioning of UNESCO Institutes and Centres". Following approval from the Union Cabinet, the centre became operational from its interim campus at Gurgaon, Haryana from 20 April 2009.
Sources: en.wikipedia.org
==== Lieutenant of the Royal Victorian Order (LVO) ==== Ian Scott Anderson, , Director, The Duke of Edinburgh's Commonwealth Study Conferences. Mark Appleby, Crown Jeweller. Colonel Jeremy David Bagshaw, , Late Coldstream Guards, 534873; lately Chief of Staff, London District, on the occasion of the Coronation of Their Majesties The King and The Queen. Major Grant Vincent Ashley Baker, Gentleman Usher to His Majesty The King. Paul David Baumann, , Receiver-General, Westminster Abbey, on the occasion of the Coronation of Their Majesties The King and The Queen. Charles Harcourt James Davies, , Private Secretary to The Princess Royal. Karen Ross Findlay, Commander, Metropolitan Police Service, on the occasion of the Coronation of Their Majesties The King and The Queen. Dr Michael Terence Isaac, Occupational Health Advisor to the Royal Household. Air Vice-Marshal Richard Howard Lacey, , lately Gentleman Usher to His Majesty The King. Charlotte Elizabeth Martin, , Deputy Head of Ceremonial, Royal Household. Jonathan David Rogerson Martin, Director of Ceremonials, Department for Culture, Media and Sport, on the occasion of the Coronation of Their Majesties The King and The Queen. Ian Donald McCowan, lately Secretary to the Governor-General of Canada. Professor Paul Mealor, Music Advisor, Honours of Scotland Service. Graham Paul Midgley, Head of Royal Travel, Royal Household. Gavin Donald Reid, Music Advisor, Honours of Scotland Service. Paul John Sedwick, Deputy Ranger, Windsor Great Park.
Commonly the protease trypsin is used, which cleaves after the positively charged arginine and lysine residues. However, trypsin is unable to cleave after a citrulline residue which is neutral. A missed cleavage after a citrulline residue together with the correct mass shift can be used as a specific and sensitive marker for citrullination, and the strategy is compatible with standard bottom-up proteomics workflows. The first comprehensive textbook on deimination was published in 2014, while the second edition was published in 2017.
== Chemistry == In terms of chemical structure, BRD-6929 is an ortho-aminoanilide or benzamide and is a close analogue of tacedinaline (CI-994), differing from it only in the addition of a thiophene ring on one of the phenyl rings.
20 February Reg Douglas, Olympic rower (1956), British Empire and Commonwealth Games gold (1954, 1958) and silver medallist (1954) (born 1930). Sir Peter Trapski, lawyer and judge, chief District Court judge (1985–1989) (born 1935). Maata Wharehoka, weaver, Māori arts advocate, community leader (Parihaka), Ngā Tohu ā Tā Kīngi Īhaka (2015) (born 1950). 21 February – John Anderson, businessman, founder of Contiki Tours (1962) (born 1938). 24 February – Khalid Sandhu, Muslim community leader and physician, president of the Federation of Islamic Associations of New Zealand (1986–1988, 1989–1990) (born 1942). 27 February Dave Gillespie, rugby union player (Otago, Wellington, national team) (born 1934). Michael Moroney, Hall of Fame Thoroughbred racehorse trainer (Brew, Tofane, Xcellent) (born 1958).
Sucrose gradient centrifugation—a linear concentration gradient of sugar (typically sucrose, glycerol, or a silica-based density gradient media, like Percoll)—is generated in a tube such that the highest concentration is on the bottom and lowest on top. A protein sample is then layered on top of the gradient and spun at high speeds in an ultracentrifuge. This causes heavy macromolecules to migrate towards the bottom of the tube faster than lighter material. During centrifugation in the absence of sucrose, as particles move farther and farther from the center of rotation, they experience more and more centrifugal force (the further they move, the faster they move). The problem with this is that the useful separation range within the vessel is restricted to a small observable window. Spinning a sample twice as long does not mean the particle of interest will go twice as far; in fact, it will go significantly further. However, when the proteins are moving through a sucrose gradient, they encounter liquid of increasing density and viscosity. A properly designed sucrose gradient will counteract the increasing centrifugal force so the particles move in close proportion to the time they have been in the centrifugal field. Samples separated by these gradients are referred to as "rate zonal" centrifugations. After separating the protein/particles, the gradient is then fractionated and collected. In biochemistry, ultracentrifugation is valuable for separating biomolecules and analyzing their physical properties.
Sources: en.wikipedia.org
Nuclear medicine is the use of open radionuclides for diagnostic and therapeutic purposes (radionuclide therapy). It also includes the use of other radioactive substances and nuclear physics techniques for functional and localization diagnostics. George de Hevesy (1885-1966) lived as a lodger and in 1923 suspected that his landlady was offering him pudding that he had not eaten the following week. He mixed a small amount of a radioactive isotope into the leftovers. When she served him the pudding a week later, he was able to detect radioactivity in a sample of the casserole. When he showed this to his landlady, she immediately gave him notice. The method he used made him the father of nuclear medicine. It became known as the tracer method, which is still used today in nuclear medicine diagnostics. A small amount of a radioactive substance, its distribution in the organism, and its path through the human body can be tracked externally. This provides information about various metabolic functions of the body. The continuous development of radionuclides has improved radiation protection. For example, the mercury compounds 203chloro-merodrin and 197chloro-merodrin were abandoned in the 1960s as substances were developed that allowed a higher photon yield with less radiation exposure. Beta emitters such as 131I and 90Y are used in radionuclide therapy. In nuclear medicine diagnostics, the beta+ emitters 18F, 11C, 13N, and 15O are used as radioactive markers for tracers in positron emission tomography (PET).
The most extensively studied category of organic molecular cages are imine-based cages, formed through Schiff base condensation reactions. This reaction involves the condensation of aldehyde and amine groups to form imine bonds (C=N). The reversible nature of imine bond formation enables error correction during synthesis, leading to highly ordered structures, where multiple imine bonds connect the organic linkers and nodes to form a well-defined cage structure. This self-correcting mechanism makes imine-based cages particularly attractive for developing new cage architectures and has contributed to their widespread study in the field. Boronic ester cages are another important class, characterized by their reversible boronic ester bonds and remarkable stability in non-aqueous conditions. Their unique chemical nature allows for post-synthetic modification, enabling the fine-tuning of cage properties after initial synthesis. This adaptability makes them valuable for applications requiring specific chemical functionalities, particularly in conditions where imine bonds are unstable. A third major category includes alkyne-based cages, which feature irreversible acetylene linkages that provide enhanced structural rigidity. The strong covalent bonds in these structures result in high thermal stability, making them suitable for applications under demanding conditions. Their rigid framework ensures consistent cavity size and shape, making them particularly valuable for selective molecular recognition applications where structural integrity is crucial.
Giant was founded in 1944 as a small grocery store in Kuala Lumpur and expanded with the opening of the Teng Minimarket Centre (TMC) in Bangsar in 1974. In 1999, Dairy Farm International Holdings bought a 90% interest in the chain, with the Teng family retaining the balance. By 2003, the holding company for the chain had changed its name to Dairy Farm Giant Retail Sdn Bhd, and the chain had eight Giant hypermarkets and 10 supermarkets as well as three Cold Storage supermarkets. Later, the company operated as a subsidiary of Dairy Farm International Holdings Limited and the name was changed to GCH Retail (Malaysia) Sdn Bhd. GCH Retail was 30%-owned by Syarikat Pesaka Antah Sdn Bhd — a company controlled by the Negeri Sembilan royal family and balance 70% by DFI Mauritius Ltd. In December 2011, Giant expanded into Vietnam. However, in February 2018, the Group disposed of its 100% interest in Asia Investment Supermarket Trading Co. Ltd. (AISTC), operating a hypermarket in Vietnam to Auchan Retail Vietnam, for net cash inflow of US$6.4 million. As such, the Group has exited from supermarket and hypermarket business in Vietnam. Beginning 2017, Giant and its peers in the hypermarket retail segment in Malaysia had been underperforming due to high operational costs, weakening consumer spending, and stiffer competition from smaller supermarkets, retailers and e-commerce. In 2019, it closed at least six outlets in Peninsular Malaysia operations. It comprises 2 hypermarkets and 2 Cold Storage outlets in Selangor, 1 each in Kedah, Perak, and Kuala Lumpur.
==== Season 2 ==== With Stewy and Sandy's takeover bid shoring up shareholder support, Logan's financier and close associates all advise that he sell the company, citing the declining relevance of legacy media in the 21st-century corporate landscape. Logan steadfastly refuses to give up his empire and decides to acquire rival news conglomerate Pierce Global Media (PGM), hoping to make Waystar too large for competitors to buy out. However, the deal falls through after the publication of a major news story exposing Waystar's decades-long cover-up of sexual exploitation on the company's cruise lines. Pierce's CEO Rhea Jarrell remains loyal to Logan after being fired from PGM and helps him navigate the company through the scandal; Logan becomes infatuated with her and eventually names her his successor, alienating Marcia. After a company whistleblower goes public with further details on the scandal, the Roys are called to testify before the Senate. Logan realizes that in order to appease the company's shareholders, he must publicly sacrifice someone close to him as a scapegoat for the scandal. Though the shareholders advise that Logan take responsibility, Logan instead chooses Kendall, who was acting CEO when the scandal was being covered up. Kendall obliges, but reverses course during a press conference the next morning by naming his father responsible for the company's historic complicity in the crimes.
Sources: en.wikipedia.org
It is a synthetic peptide triagonist that engages GIP, GLP-1, and glucagon receptors. Investigational compounds in this class are studied for metabolic conditions rather than for a single organ system.
No regulatory agency has approved it for any indication. It remains an investigational product studied within controlled clinical trial programs.
A dual agonist engages two receptor targets, typically GIP and GLP-1. A triagonist adds glucagon receptor activity, which is intended to influence energy expenditure alongside appetite and glucose handling.
指同一个分子能激活 GIP、GLP-1 和胰高血糖素三类受体。它与只激活一到两种受体的同类分子在设计思路上有所区别。这种设计的目的在于覆盖更多代谢调节通路。